It is with a real sense of gratitude that the Drug Enforcement Administration and the Biden administration decided to continue this flexibility that's now been in place for almost half a decade so that we can continue to take the time to get the permanent framework right. ... It was going to be calamitous if we were going to allow for this flexibility to expire December 31 this year.
Continuity of care would be severed for hundreds of thousands, if not more, patients. We need to prevent abuse of the flexibilities and create a special registration process allowing medical professionals to register with the agency to virtually prescribe controlled substances.
Collection
[
|
...
]